Arbutus' imdusiran achieves functional cure in chbv patients when combined with a short course of interferon

50% of patients who had baseline hbsag levels less than 1000 iu/ml achieved functional cure in cohort a1 of the im-prove i phase 2a clinical trial
ABUS Ratings Summary
ABUS Quant Ranking